0000945769-12-000056.txt : 20121212
0000945769-12-000056.hdr.sgml : 20121212
20121212170711
ACCESSION NUMBER: 0000945769-12-000056
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121210
FILED AS OF DATE: 20121212
DATE AS OF CHANGE: 20121212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: April Gary M
CENTRAL INDEX KEY: 0001463267
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-20424
FILM NUMBER: 121259831
MAIL ADDRESS:
STREET 1: C/O HI-TECH PHARMACAL CO., INC.
STREET 2: 369 BAYVIEW AVENUE
CITY: AMITYVILLE
STATE: NY
ZIP: 11701
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HI TECH PHARMACAL CO INC
CENTRAL INDEX KEY: 0000887497
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 112638720
STATE OF INCORPORATION: NY
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 369 BAYVIEW AVENUE
CITY: AMITYVILLE
STATE: NY
ZIP: 11701
BUSINESS PHONE: 5167898228
MAIL ADDRESS:
STREET 1: 369 BAYVIEW AVE.
CITY: AMITYVILLE
STATE: NY
ZIP: 11701
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2012-12-10
0000887497
HI TECH PHARMACAL CO INC
HITK
0001463267
April Gary M
C/O HI-TECH PHARMACAL CO., INC.
369 BAYVIEW AVENUE
AMITYVILLE
NY
11701
0
1
0
0
President, HCP Division
Common Stock
2012-12-10
4
M
0
1875
5.83
A
1875
D
Common Stock
2012-12-10
4
M
0
1875
19.59
A
3750
D
Common Stock
2012-12-10
4
M
0
1876
22.25
A
5626
D
Common Stock
2012-12-10
4
S
0
5626
35.44
D
0
D
Stock Option (Right to Buy)
5.83
2012-12-10
4
M
0
1875
0
D
2009-11-13
2018-11-13
Common Stock
1875
0
D
Stock Option (Right to Buy)
19.59
2012-12-10
4
M
0
1875
0
D
2010-11-12
2019-11-12
Common Stock
1875
1875
D
Stock Option (Right to Buy)
22.25
2012-12-10
4
M
0
1876
0
D
2011-11-10
2020-11-10
Common Stock
1876
3750
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.21 to $35.71, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote [1] of this Form 4.
Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s Amended and Restated Stock Option Plan, which is a 16b-3 Plan.
Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 2009 Stock Option Plan, which is a 16b-3 Plan.
The option became or becomes exercisable in four (4) equal annual installments beginning on the first anniversary of the grant date.
Other than the options to acquire 5,625shares reflected on this form as still held by Mr. April following the reported transactions, Mr. April is also the holder of additional options to acquire 25,000 shares of Hi-Tech common stock (for total options to acquire 30,625 shares still held by Mr. April), which options were granted on various dates, with various exercise prices, exercise dates, and expiration dates.
Gary M. April
2012-12-12